Identification of circRNA Expression Profile and Potential Systemic Immune Imbalance Modulation in Premature Rupture

Dongni Huang1,2, Yuxin Ran1,2, Ruixin Chen3

  • 1Women and Children's Hospital of Chongqing Medical University (Chongqing Health Center for Women and Children), Chongqing, China.

Insights

Circular RNAs (circRNAs) are implicated in premature rupture of membranes (PROM). This study reveals circRNA-mediated immune imbalances and collagen disruption as potential causes of PROM, offering new diagnostic and therapeutic avenues.

Area of Science:

  • Molecular Biology
  • Genetics
  • Obstetrics

Background:

  • Premature rupture of membranes (PROM) is a leading cause of perinatal morbidity and mortality.
  • Circular RNAs (circRNAs) are increasingly recognized as key regulators in various diseases.
  • The role and regulatory mechanisms of circRNAs in PROM are not well understood.

Purpose of the Study:

  • To investigate circRNA expression profiles in PROM.
  • To elucidate circRNA-miRNA-mRNA regulatory networks in PROM.
  • To identify potential circRNA biomarkers and therapeutic targets for PROM.

Main Methods:

  • CircRNA microarray analysis of plasma and fetal membranes from PROM and control groups.
  • Bioinformatic analysis including construction of circRNA-miRNA-mRNA networks.
  • Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway, and Gene Set Enrichment Analysis (GSEA).

Main Results:

  • Identified 1,459 differentially expressed circRNAs (DECs) in PROM (406 upregulated, 1,053 downregulated).
  • Constructed a regulatory network involving 22 circRNA-miRNA and 128 miRNA-mRNA pairs.
  • DECs are significantly associated with immune-related pathways and extracellular matrix regulation, with 11 shared host genes in fetal membranes and plasma.

Conclusions:

  • CircRNAs may predispose individuals to PROM by disrupting systemic and local immune balance and collagen structure.
  • This study provides the first comprehensive landscape of circRNAs in PROM.
  • Findings open new avenues for PROM diagnosis and treatment through circRNA-based strategies.